Medical assessment after a pre-eclampsia: Why? For whom? When? How? For what purpose;La consultation médicale après une pré-éclampsie: Pourquoi ? Pour qui ? Quand ? Comment ? Pour trouver quoi ?

Revue de Medecine Interne

Volumn 31, Issue 11, 2010, Pages 766-771

  Pourrat, O ^a   Pierre, F ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Arterial hypertension; Chronic renal disease; Obstetric medicine; Postnatal visit; Pre eclampsia; Thrombophilia

Indexed keywords

ARTERY DISEASE; AUTOIMMUNE DISEASE; CONSULTATION; FOLLOW UP; HEART DISEASE; HUMAN; KIDNEY DISEASE; LONG TERM CARE; MATERNAL HYPERTENSION; MEDICAL ASSESSMENT; METABOLIC DISORDER; POSTNATAL CARE; PREECLAMPSIA; RISK FACTOR; SHORT SURVEY; THROMBOPHILIA;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNAL MEDICINE; MALE; OBSTETRICS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTNATAL CARE; PRE-ECLAMPSIA; PREGNANCY;

EID: 77958152767     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.07.011     Document Type: Short Survey

References (46)

1. Beaufils M. Hypertension artérielle gravidique. Rev Med Interne 2002, 23:927-938.
2. Verspyck E., Marpeau L. Thrombophilies et pathologies vasculaires placentaires. Revue de la littérature. Rev Med Interne 2005, 26:103-108.
3. Roberts J.M., Redman C.W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993, 341:1447-1451.
4. Tsatsaris V., Fournier T., Winer N. Physiopathologie de la pré-éclampsie. J Gynecol Obstet Biol Reprod (Paris) 2008, 37:16-23.
5. Pourrat O., Pierre F., Magnin G. Le syndrome HELLP: les dix commandements. Rev Med Interne 2009, 30:58-64.
6. Funai E.F., Freidlander Y., Paltiel O., Tiram E., Xue X., Deutsch L., et al. Long-term mortality after pre-eclampsia. Epidemiology 2005, 16:206-215.
7. Pourrat O., Pierre F. Pronostic obstétrical, rénal et vasculaire à long terme dans les suites de la prééclampsie. Ann Fr Anesth Reanim 2010, 29:e155-e160.
8. Pourrat O. La médecine obstétricale: une mission de choix pour l'interniste. Rev Med Interne 2004, 25:419-420.
9. Pourrat O., Audebert M., Soubeyran C., Pierre F., Magnin G. Résultats du bilan pratiqué en consultation de médecine Interne après une prééclampsie (103 cas). Rev Med Interne 2006, 27(Suppl. 3):S356-S357. (abstract).
10. Wilson B.J., Watson M.S., Prescott G.J. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003, 326:845-849.
11. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long-term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001, 323:1213-1217.
12. Vikse B.E., Irgens L.M., Bostad L., Iversen B.M. Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 2006, 17:837-845.
13. Laivuori H., Tikkanen M.J., Ylikorkala O. Hyperinsulinaemia 17 years after pre-eclamptic first pregnancy. J Clin Endocrinol Metab 1996, 81:2908-2911.
14. Chambers J.C., Fusi L., Malik I.S., Haskard D.O., De Swiet M., Kooner J.S. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001, 285:1607-1612.
15. Hubel C.A., Powers R.W., Snaedal S., Gammill H.S., Ness R.B., Roberts J.M., et al. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008, 51:1499-1505.
16. Rossi P., Tauzin L., Grosse C., Simeoni U., Frances Y. Impact de l'âge gestationnel et du poids de naissance sur le devenir cardiovasculaire à long terme. Rev Med Interne 2007, 28:545-551.
17. Pourrat O., Poupard V., Soubeyran C., Magnin G., Pierre F. Les recommandations sur la pré-éclampsie sont-elles appliquées dans le postpartum ? Enquête dans un réseau de périnatalité (114 cas). Rev Med Interne 2009, 30(Suppl. 2):S50.
18. Samwiil L., Mercer C., Jarrett P., O'Malley S. Genetics of Pre-Eclampsia Collaborative Study (GOPEC) Research Midwives. Blood pressure and urinalysis are often omitted in women who have suffered pre-eclampsia at their six-week postnatal check. BJOG 2004, 111:623-625.
19. Levine R.J., Maynard S.E., Qian C., Lim R.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.
20. Lowe S., Nelson-Piercy C., Rosene-Montella K. Obstetric medicine: bridging the gap. Obstet Med 2009, 2:45.
21. Askie L.M., Duley L., Henderson-Smart D.J., Stewart L.A. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007, 369:1791-1798. PARIS Collaborative Group.
22. Inskip H.M., Crozier S.R., Godfrey K.M., Borland S.E., Cooper C., Robinson S.M., et al. Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study. BMJ 2009, 338:b481.
23. Haute Autorité de santé. Comment mieux informer les femmes enceintes. Recommandations pour la pratique clinique avril 2005, pp. 12-13. Disponible en ligne: http://www.has-sante.fr/portail/jcms/c-454394/comment-mieux-informer-les-femmes-enceintes.
24. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354:2443-2451.
25. Magee L.A., Ornstein M.P., von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999, 318:1332-1336.
26. McCowan L.M., Dekker G.A., Chan E., Stewart A., Chappell L.C., Hunter M., et al. SCOPE consortium. Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. BMJ 2009, 338:b1081.
27. Pipkin F.B. Genetics of Preeclampsia Consortium. Smoking in moderate/severe preeclampsia worsens pregnancy outcome, but smoking cessation limits the damage. Hypertension 2008, 51:1042-1046.
28. Dekker G.A., De Vries J.I.P., Doelitzsch P.M., Huijgens P.M., Von Blomberg B.M.E., Jackobs C. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995, 173:1042-1048.
29. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999, 340:9-13.
30. Lin J., August P. Thrombophilias preeclampsia: a meta-analysis. Obstet Gynecol 2005, 105:182-192.
31. Société française d'anesthésie et de réanimation (Sfar) ; Collège national des gynécologues et obstétriciens français (CNGOF) ; Société française de médecine périnatale (SFMP) ; Société française de néonatalogie (SFNN). Prise en charge multidisciplinaire de la prééclampsie. Recommandations formalisées d'experts communes 2008. Ann Fr Anesth Reanim 2009;28:275-81. Disponible en ligne http://www.sfar.org%20/t/IMG/pdf/rfe-%20preeclampsie.pdf.
32. Royal College Gynecol Obstet. Pre-eclampsia-study group statement. 2003. Disponible en ligne à http://www.rcog.org.uk/index.asp? PageID=312.
33. Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J. American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edn). Chest 2008, 133(6 (Suppl.)):844S-886S.
34. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
35. Pernod G., Biron-Andreani C., Morange P.E., Boehlen F., Constans J., Couturaud F., et al. Recommendations pour la recherche de facteurs biologiques de risque dans le cadre de la maladie thromboembolique veineuse. J Mal Vasc 2009, 34:156-203.
36. Haute Autorité de santé. Thrombophilie et grossesse - prévention des risques thrombotiques maternels et placentaires. Ann Med Interne 2003;154:345-53. Disponible en ligne- http://www.has.sante.fr/portail/upload/docs/application/pdf/Thrombophilie%20grossesse_court.%20pdf.
37. Sibai B.M., Mercer B., Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991, 165(5 Pt. 1):1408-1412.
38. Van Rijn B.B., Hoeks L.B., Bots M.L., Franx A., Bruinse H. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006, 195:723-728.
39. Dreyfus M., Hedelin G., Kutnahorsky R., Lehmann M., Viville B., Langer B., et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol 2001, 97:29-34.
40. Branch D.W., Porter T.F., Rittenhouse L., Caritis S., Sibai B., Hogg B., et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001, 184:825-834.
41. Facchinetti F., Marozio L., Frusca T., Grandone E., Venturini P., Tiscia G.L., et al. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009, 200. 46.e1-5.
42. Walters B.N.J. Obstetric medicine, its premise and promise. Aust N Z J Obstet Gynaecol 2004, 44:295-297.
43. Pourrat O. Obstetric medicine: a key role for the internist. Eur J Int Med 2005, 16:220.
44. Pourrat O. « Quelles questions-réponses dans le dialogue internistes-obstétriciens ? » Dans: « Diagnostics Difficiles en Médecine Interne », H. Rousset, D. Vital-Durand, JL Dupond, M. Pavic. 2008, Ed. Maloine, Paris, 3e ed. (p. 735-51).
45. Saade G.R. Pregnancy as a window to future health. Obstet Gynecol 2009, 114:958-960.
46. Magnussen E.B., Vatten L., Smith G.D., Romundstad P.R. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 2009, 114:961-970.